UW-Madison spin-off company studies potential autism identifiers
By Peter Coutu | Feb. 29, 2016UW-Madison spin-off organization Stemina Biomarker Discovery is attempting to create a biological method to diagnose autism by screening blood samples. CEO Elizabeth Donley and UW-Madison professor in the Department of Animal Sciences Gabriela Cezar founded the company in 2006, according to a university release. The company received $2.7 million from the National Institute of Mental Health in August 2015 to fund the study, which is titled the Children’s Autism Metabolome Project.